Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial

Mostrar otras versiones (1)

BACKGROUND: The ability to quantify an immune response after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential. This study assessed the clinical utility of the quantitative Roche Elecsys(®) Anti-SARS-CoV-2 S assay (ACOV2S) using samples from the 2019-nCoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Jochum, Simon, Kirste, Imke, Hortsch, Sayuri, Grunert, Veit Peter, Legault, Holly, Eichenlaub, Udo, Kashlan, Basel, Pajon, Rolando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807632/
https://www.ncbi.nlm.nih.gov/pubmed/35126362
http://dx.doi.org/10.3389/fimmu.2021.798117
Mostrar todas las versiones(2)

Ejemplares similares